Sacurise 50 Tablet is used to manage chronic heart failure with reduced ejection fraction in adults. It combines two active ingredients: sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker. This combination helps relax blood vessels, reduce fluid retention, and decrease the heart's workload, thereby improving heart function and reducing the risk of hospitalisation and cardiovascular death.
In addition to managing heart failure, it also aids in reducing the risk of cardiovascular death and hospitalisation in patients with HFrEF. The tablet form allows for a convenient way of oral dosing.
Before you start taking this medicine, consult your doctor who will provide guidance on the appropriate dosage and frequency. It's crucial that you inform your doctor about any other ongoing medications or pre-existing conditions. If you experience any side effects while on this medication, notify your doctor promptly. For best results, continue the medication for the duration prescribed by your doctor.